FindTrial
Sign In

Estimation of the prevalence and detection of risk factors for the development of arrhythmia-induced cardiomyopathy in patients with supraventricular arrhythmias, especially atrial fibrillation and atrial flutter

Estimation of the prevalence and detection of risk factors for the development of arrhythmia-induced cardiomyopathy in patients with supraventricular arrhythmias, especially atrial fibrillation and atrial flutter

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035062
Enrollment
450
Registered
2024-10-30
Start date
2024-12-03
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia-induced cardiomyopathy

Interventions

Group 1: Patients with atrial fibrillation/atrial flutter who could develop arrhythmia-induced cardiomyopathy. Survey of the number of cases over approx. one year. Additional anamnestic questionnaire

Sponsors

Carl von Ossietzky Universität Oldenburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with atrial fibrillation/flutter in whom cardioversion is planned

Exclusion criteria

Exclusion criteria: - Patients with arrhythmias other than atrial fibrillation/flutter atrial fibrillation/flutter

Design outcomes

Primary

MeasureTime frame
Determination of the monocentric prevalence for the development of arrhythmia-induced cardiomyopathy—

Secondary

MeasureTime frame
Identification of risk factors and the probability of developing a recurrence—

Countries

Germany

Contacts

Public ContactSimon Kochhäuser

Niels-Stensen-Klinik Marienhospital Osnabrück

simon.kochhaeuser@nsk.de+49 5413268809

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026